How Much Did Puremax Labs Raise?
Funding & Key Investors

Puremax Labs has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. The firm recently finalized a major strategic investment totaling $250K, which contributes to an aggregate capital position of $250K. This infusion of liquidity underscores the company's robust operational health and its capacity to attract institutional backing within the competitive nutritional supplement landscape.

What is Puremax Labs?

Puremax Labs
ManufacturingHealth & Nutrition ProductsRetail

Puremax Labs operates as a specialized manufacturer and direct-to-consumer retailer of premium nutritional supplements. By focusing on the intersection of efficacy and consumer experience, the company has carved out a distinct market niche with its flagship product, YummyVite. Their portfolio spans critical wellness categories, including cardiovascular support, cognitive health, digestive wellness, and immune system fortification. By leveraging both proprietary e-commerce channels and high-traffic marketplaces like Amazon, Puremax Labs effectively captures the growing demographic of health-conscious consumers who prioritize convenience without compromising on ingredient quality or product palatability.

How much funding has Puremax Labs raised?

Puremax Labs has raised a total of $250K across 1 funding round:

2025

Debt

$250K

Debt (2025): $250K with participation from Northeast Bank

Key Investors in Puremax Labs

Northeast Bank

A regional financial institution providing commercial banking services and debt financing solutions to support corporate growth and operational stability.

What's next for Puremax Labs?

With this late-stage financing, Puremax Labs is well-positioned to accelerate its market penetration and operational scaling. The strategic deployment of this capital will likely focus on supply chain optimization, expanded research and development for new product formulations, and aggressive customer acquisition strategies. As the nutraceutical industry continues to consolidate, Puremax Labs' ability to maintain high-quality standards while scaling production will be the primary determinant of its long-term valuation. The company is expected to leverage this financial runway to solidify its brand equity and potentially explore new distribution partnerships to further diversify its revenue streams in the coming fiscal quarters.

See full Puremax Labs company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturing
AppliancesManufacturingHousehold GoodsFlowers, Gifts & Specialty StoresRetail
ManufacturingTextiles & ApparelArchitecture, Engineering & DesignConstructionFitness & Dance FacilitiesHospitality
Automotive PartsManufacturingAutomobile Parts StoresRetail

Frequently Asked Questions Regarding Puremax Labs Financial Insights

What are the most recent funding rounds that Puremax Labs has completed, and what were the funding rounds?
Puremax Labs has recently completed 1 funding rounds: Debt on Mar 31, 2025.
What is the total amount of funding Puremax Labs has raised to date?
Puremax Labs has raised a total of $250K in funding to date.
How many funding rounds has Puremax Labs completed?
Puremax Labs has completed 1 funding rounds.
How much funding did Puremax Labs raise in its most recent funding round?
Puremax Labs raised $250K in its most recent funding round.
Who are the lead investors in Puremax Labs's latest funding round?
The lead investor in Puremax Labs's latest funding round was Northeast Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Puremax Labs's history?
The largest funding round in Puremax Labs's history was $250K.
See more information about Puremax Labs